European Dry Powdered Inhaler Market Growth, Size, Share, Industry Report and Forecast 2019-2025
The European Dry Powdered Inhaler market was valued at around $3.7 billion in 2018 and is anticipated to grow at a substantial rate of 2.1% during the forecast period. Major countries that will contribute to the dry powdered inhaler market within the region includes UK, Germany, France, Italy, and Spain. A significant number of companies, research, patient base has been observed in the market due to which a significant growth can be observed in the market. According to the International Monetary Fund (IMF), Europe is home to around 740 million people and the GDP of the European Union is $19.7 trillion in 2017. As per Organization for Economic Co-operation and Development (OECD), the self-reported asthma rate and COPD rate by European Union countries were 6.1% and 4.0% respectively and it has been found out that the rate of prevalence of diseases are higher in women as compared to men. This is expected to drive the regional business growth of the dry powdered inhaler market.
To Request a Sample of our
Report on European Dry Powdered Inhaler Market: https://www.omrglobal.com/request-sample/european-dry-powdered-inhaler-market
The European dry powdered inhaler
market is segmented based on type, application, and end-user. Based on the
type, preventive, reliever, and long-acting bronchodilators inhaler are
analyzed. The preventive dry powdered inhaler segment led the global dry
powdered inhaler market in 2018. Preventive inhalers are most widely used in
the treatment of asthma in children and adults. These inhalers do not entail
side effects for long-term use, and exceptionally decreases the possibility of
an asthma exacerbation. The preventive inhalers further reduce the airways
swelling and hence, are recommended for regular use by the physician. Some of
the preventive inhalers available in the market include Budesonide and
Fluticasone. Moreover, based on the application, the market has been classified
into asthma and COPD diseases. In addition, based on the end-user, homecare and
hospitals and clinics have been analyzed.
(Get 15% Discount on
Buying this Report)
A full Report of European Dry
Powdered Inhaler Market is Available at: https://www.omrglobal.com/industry-reports/european-dry-powdered-inhaler-market
European Dry Powdered
Inhaler Market Segmentation
By Type
·
Preventive Inhaler
·
Reliever Inhaler
·
Long Acting Bronchodilators Inhaler
By Application
·
Asthma
·
Chronic Obstructive Pulmonary Disease (COPD)
By End-User
·
Homecare
·
Hospitals and Clinics
Regional Analysis
·
UK
·
Germany
·
France
·
Italy
·
Spain
Rest of Europe
Company Profiles
·
3M Co.
·
Acorda Therapeutics, Inc.
·
Adamis Pharmaceuticals Corp.
·
Adherium Ltd.
·
AstraZeneca PLC
·
Bespak
·
Boehringer Ingelheim International GmbH
·
Chiesi Farmaceutici S.P.A.
·
GF Health
·
GlaxoSmithKline PLC
·
H&T Presspart Manufacturing Ltd.
·
Koninklijke Philips N.V.
·
Novartis AG
·
Omron Healthcare Inc.
·
ResMed Corp.
·
Pulmatrix Inc.
·
Savara, Inc.
·
Teicos Pharma Ltd.
·
Teva Pharmaceuticals Industries Ltd.
·
Vitalograph Ltd.
Reasons to buy from us –
1. We cover more than 15 major industries,
further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for
investigation.
4. Our expert research analysts answer all your
questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment